Innovations in Cardiac Ablation Technology Take Center Stage: Key Companies Leading the PFA Revolution

News provided by

Oct 19, 2023, 12:30 ET

DUBLIN, Oct. 19, 2023 /PRNewswire/ -- The "Pulsed Field Ablation Market by Therapeutic Area, Product Components, Application Areas, Source of Ablation, and Key Geographical Regions: Market Share of Key Companies, Industry Trends and Global Forecasts, 2023-2035" report has been added to ResearchAndMarkets.com's offering.

The Pulsed Field Ablation (PFA) market, a rapidly expanding segment within the cardiac ablation sector, is set to witness robust growth with a projected Compound Annual Growth Rate (CAGR) of approximately 40% during the forecast period of 2023-2035. This surge is driven by the demand for safer and more effective alternatives to traditional surgical procedures, especially in the treatment of cardiac rhythm-related disorders such as atrial fibrillation.

In recent years, the medical community has been actively exploring minimally invasive procedures that offer reduced pain, shorter recovery times, and improved patient outcomes. These techniques have found a niche in the vast atrial fibrillation market, where conventional treatments often come with drawbacks like extensive scarring, lengthy hospital stays, and a higher risk of complications. As a result, the spotlight has shifted towards ablation therapies, which employ energy sources to target and destroy abnormal tissues without invasive surgery. However, conventional ablation methods primarily rely on thermal energy, which can lead to tissue overheating and post-procedural pain.

Enter pulsed field ablation (PFA), a game-changing approach harnessing high-voltage electrical pulses delivered in short bursts. PFA is a non-thermal ablation process that enables precise targeting of abnormal tissues while preserving surrounding healthy cells. This innovation significantly reduces the risk of complications and discomfort post-procedure.

Atrial fibrillation, a cardiac rhythm disorder affecting millions globally, has seen a substantial rise in prevalence, with the elderly population facing a higher risk. In the United States alone, around 9% of individuals aged 65 and older are afflicted by atrial fibrillation. Europe, too, grapples with an escalating prevalence, making it a pressing public health concern. Improved detection and diagnosis, coupled with lifestyle-related risk factors, have contributed to this surge in cases.

PFA technology has shown great promise in addressing atrial fibrillation and other cardiac arrhythmias. By creating precise scars in cardiac tissue, PFA blocks irregular electrical signals, restoring normal heart rhythm. Moreover, PFA's potential extends beyond cardiology, with applications in oncology for treating solid tumors, respiratory disorders, and dermatological disorders by precisely removing skin lesions.

PFA stands out for its safety and efficacy compared to traditional thermal ablation techniques. Its tissue-selective functionality reduces risks, such as phrenic palsy and esophageal injury. Importantly, PFA utilizes apoptosis, leading to non-inflammatory responses and quicker post-procedure recovery times.

The Pulsed Field Ablation Market: Distribution by Therapeutic Area, Product Components, Application Areas, Source of Ablation, and Key Geographical Regions report for 2023-2035 provides a comprehensive overview of this rapidly evolving medical devices segment. Notably, it highlights the efforts of numerous stakeholders, including key companies leading the charge in PFA technology.

Key PFA Companies:

Abbott
AccuPulse Medical
Acutus Medical
AngioDynamics
Arga Medtech
AtriAN Medical
Aurigen Medical
Biosense Webster
Boston Scientific
CathRx
ElectroPhysiology Frontiers
EnChannel Medical
Galvanize Therapeutics
Hangzhou Dinova EP Technology
Kardium
Medtronic
Mirai Medical
Pulse Biosciences
Tianjin Intelligent Health Medical

Recent Developments:

9th World Congress on Cardiology and Cardiovascular Therapeutics (July 2023): In July 2023, the 9th World Congress on Cardiology and Cardiovascular Therapeutics was held in Vancouver, Canada, showcasing the latest advancements in cardiac therapies, including Pulsed Field Ablation.
Pulse Biosciences Raises $65 Million (May 2023): Pulse Biosciences raised an impressive $65 million in a private placement round led by Robert W. Duggan, executive chairman at Pulse Biosciences. The funds will be utilized for the development of the company's proprietary Nanosecond Pulsed Field AblationT (nsPFAT) technology for the treatment of atrial fibrillation.
Medtronic Receives CE Mark Approval (March 2023): Medtronic received CE mark approval for the AfferaT Mapping and Ablation System for the treatment of atrial fibrillation. The system includes Sphere-9T Catheter and AfferaT Prism-1 Mapping Software, enhancing treatment options for atrial fibrillation patients.

Key Topics Covered:

1. PREFACE

2. RESEARCH METHODOLOGY

3. ECONOMIC AND OTHER PROJECT SPECIFIC CONSIDERATIONS

4. EXECUTIVE SUMMARY

5. INTRODUCTION

6. PULSED FIELD ABLATION DEVICES: MARKET LANDSCAPE

7. PRODUCT COMPETITIVENESS ANALYSIS

8. PULSED FIELD ABLATION DEVICE DEVELOPERS: DETAILED COMPANY PROFILES

9. PULSED FIELD ABLATION DEVICE DEVELOPERS: TABULATED COMPANY PROFILES

10. RECENT DEVELOPMENTS AND INITIATIVES

11. PATENT ANALYSIS

12. GLOBAL EVENTS ANALYSIS

13. CASE STUDY: POTENTIAL PARTNERS OF PULSED FIELD ABLATION DEVICE DEVELOPERS

14. MARKET IMPACT ANALYSIS: DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES

15. GLOBAL PULSED FIELD ABLATION MARKET

16. PULSED FIELD ABLATION MARKET, BY GEOGRAPHY

17. PULSED FIELD ABLATION MARKET, BY THERAPEUTIC AREA

18. PULSED FIELD ABLATION MARKET, BY PRODUCT COMPONENTS

19. PULSED FIELD ABLATION MARKET FOR CARDIOVASCULAR DISORDERS, BY PRODUCT COMPONENTS

20. PULSED FIELD ABLATION MARKET FOR CARDIOVASCULAR DISORDERS, BY APPLICATION AREA

21. PULSED FIELD ABLATION MARKET FOR CARDIOVASCULAR DISORDERS, BY SOURCE OF ABLATION

22. PULSED FIELD ABLATION MARKET FOR CARDIOVASCULAR DISORDERS, BY GEOGRAPHY

23. PULSED FIELD ABLATION MARKET FOR ONCOLOGICAL DISORDERS, BY GEOGRAPHY

24. PULSED FIELD ABLATION MARKET FOR ONCOLOGICAL DISORDERS, BY PRODUCT COMPONENTS

25. PULSED FIELD ABLATION MARKET FOR ONCOLOGICAL DISORDERS, BY TYPE OF CANCER

26. PULSED FIELD ABLATION MARKET FOR RESPIRATORY DISORDERS, BY GEOGRAPHY

27. PULSED FIELD ABLATION MARKET FOR RESPIRATORY DISORDERS, BY PRODUCT COMPONENTS

28. PULSED FIELD ABLATION: SALES FORECAST OF LEADING PLAYERS

29. CONCLUDING REMARKS

30. APPENDIX 1: TABULATED DATA

31. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

Companies Mentioned

Abbott
AccuPulse Medical
Acutus Medical
Adagio Medical
Affera
Analog Devices
AngioDynamics
APN Health
Arga Medtech
AtriAN Medical
AuriGen Medical
Biosense Webster
BioSig Technologies
BIOTRONIK
Boston Scientific
Cardiac Designs
CardioFocus
CardioNXT
Catheter Precision
CathRx
Chongqing University
Coherex Medical (Acquired by Biosense Webster)
CoreMap
Corify Care
CRC EP
ElectroPhysiology Frontiers
EnChannel Medical
EP Map-System
FARAPULSE
Field Medical
Gala Therapeutics
Galaxy Medical
Galvanize Therapeutics
Gradient Medical
Hangzhou Dinova EP Technology
Hangzhou Ruidi Biotechnology
Innovative Health
Japan Lifeline
Kardium
Medtronic
MicroPort
Minnetronix Medical
Mirai Medical
Ningbo No. 1 Hospital
Peerbridge Health
Philips
Pulse Biosciences
RBC Medical Innovations
Remedicine
Rhythm AI
Rhythm Xience (Acquired by Acutus Medical)
Shanghai Changhai Hospita
Shanghai Xuanyu Medical Equipment
Sichuan Jinjiang Electronic Medical Device Technology-JJET
Sirona Medical
St. Paul's Hospital
Suzhou Aikemai Medical Technology
Tianjin Intelligent Health Medical
University of Wisconsin-Madison
Utrecht University
Zhejiang Jiashi Shangyang Medical Technology
Zhouling Medical Appliances

For more information about this report visit https://www.researchandmarkets.com/r/9tggl9

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

SOURCE Research and Markets